Explore how the intersection of medical device design and disruptive technologies is reshaping the healthcare industry. Discover how new players armed with AI-driven devices and advanced manufacturing tools are pushing boundaries and revolutionizing the future of medical innovation. Steve Levine, Senior Director at Dassault Systèmes, shares insights on the next plateau of medical device design.

In brain health, traditional inpatient monitoring systems present a myriad of barriers. They often require travel to a specialized health center, are cumbersome and restrictive for patients, and technical requirements and limitations impede providers’ ability to even provide such services. Today, advancements are disrupting this model to fuel the growth of person-enabled health and the ongoing treatment of chronic neurological disorders and conditions

Using artificial intelligence in clinical environments will change the cybersecurity landscape for health systems. Mr. Jobe explains how.

Dr. Richard Lazzaro recognized that there was an opportunity to create a less invasive option to treat tracheobronchomalacia (TBM) and improve the quality of life for millions of patients; in 2013, he pioneered robotically assisted, minimally invasive tracheal repair (MITR™). He later co-founded Lazzaro Medical to develop the LM Scaffold System™ which is set to further improve the treatment of Tracheobronchomalacia (TBM) by offering a minimally invasive, robotically-assisted approach that also ensures precision, safety, and effectiveness. With the recent $2.4 million Direct to Phase II SBIR grant from the NIH, Lazzaro Medical is poised to evolve TBM treatment, providing patients with a solution that addresses the root cause of their symptoms and help improve patient outcomes.